brca | 59562

BRCA Screening

Keywords:

hereditary cancer

prostate carcinoma

Status

Material

Blood EDTA

EDTA tube, purple (6)

Hint

Screening auf Mutationen und Gendosisveränderungen in den Genen BRCA1 und BRCA2. | Declaration of consent for genetic examination in accordance with GUMG required (see OF Human genetics or www.viollier.ch/en/SGMG_consent) | There is a possibility of excess information occurring with this analysis. This will be communicated, unless it is noted otherwise when placing the order.

Min. volume

4 mL

Stability

1 week / 2-8°C

Duration

2 weeks

Frequency

2 x per week

Method

Next Generation Sequencing